A novel approach to the preparation and scale up production of pentoxifylline controlled release tablets:ii. bioequivalence study
- At: 2005 FIP Congress in Cairo (Egypt)
- Type: Poster
- By: SHARAF EL DIN, Mohamed Ashraf (Five Fives Co., Quality Departments, Alexandria, Egypt)
- Co-author(s): Sharaf (A. A. K. Co., CAIRO, Egypt)
Elkhesen (Fac.of Pharmacy , Cairo univ., CAIRO, Egypt)
Khattab (Fac. of Pharmacy, Azhar Univ., CAIRO, Egypt)
Nour (Fac.of Pharmacy , Cairo univ., CAIRO, Egypt)
Aim: The bioequivalence of a single 600-mg doses of pentoxifylline, newly formulated controlled release tablets, (Treatment A) and Trental[RSYMBOL] tablets (Treatment B) were evaluated in a crossover study in 12 healthy volunteers under fasting conditions.
Experimental: In vitro dissolution profiles were determined for the new formulation and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.